Tineke Smilde - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Tineke Smilde

This paper was not found in any repository, but could be made available legally by the author.

2020 Joost M. Blok

ORCID

, Harmke J. Groot

ORCID

, Eline H. Huele, Ronald de Wit, Simon Horenblas, Janine Nuver, Gerard Groenewegen

ORCID

, J. L. H. Ruud Bosch

ORCID

, J. Alfred Witjes, Jacqueline M. Tromp, Peter J. M. de Brouwer, Hetty A. van den Berg, Ben G. L. Vanneste, Tineke J. Smilde

ORCID

, Maureen J. B. Aarts and 3 other authors

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer

Upload

This paper is made freely available by the publisher.

2018 Julia van Steenhoven, Anne Kuijer, Paul van Diest, Joost van Gorp, Marieke Straver, Sjoerd Elias, Jelle Wesseling, Emiel Rutgers, Johanna Timmer-Bonte, Peter Nieboer, Tineke Smilde

ORCID

, Alex Imholz, Charlotte Blanken, Sabine Siesling, Thijs van Dalen

Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 R. J. W. van Kampen, B. L. T. Ramaekers, D. J. A. Lobbezoo, M. de Boer, M. W. Dercksen, F. van den Berkmortel, T. J. Smilde

ORCID

, A. J. van de Wouw

ORCID

, F. P. J. Peters, J. M. G. van Riel, N. A. J. B. Peters, V. C. G. Tjan-Heijnen, M. A. Joore

ORCID

Real-world and trial-based cost-effectiveness analysis of bevacizumab in HER2-negative metastatic breast cancer patients: a study of the Southeast Netherlands Breast Cancer Consortium

Upload

Missing publications? Search for publications with a matching author name.